Regenerative Medicine News
ISTO Technologies Initiates Phase II Trial of NuQu®: Novel Cell-based Therapy for the Treatment of Painful Spinal Discs
October 22, 2012 - (ISTO) - " ISTO Technologies, Inc. announced today that it is initiating a Phase II trial to further evaluate the efficacy and safety of its NuQu® cell-based therapy for the treatment of pain and disability associated with degenerated spinal discs." Read Full Article
Posted on
13-Nov-12
by Gallerno, Jacob
Tags:
Science and Industry News
Trackback Url
|
Link to this post
| Bookmark this post with:
